Avalo Therapeutics, Inc. (AVTX)
NASDAQ·Healthcare·Biotechnology
$16.16
-5.94%
Mkt Cap $1.04B
Analyst Ratings
Buy
12
Hold
0
Sell
0
Price Target (14 analysts)
$45.13
Range $30.00 – $60.00
Implied Upside
+179.3%
Consensus $45.13 vs current $16.16
NASDAQ·Healthcare·Biotechnology
$16.16
-5.94%
Mkt Cap $1.04B
Buy
12
Hold
0
Sell
0
Price Target (14 analysts)
$45.13
Range $30.00 – $60.00
+179.3%
Consensus $45.13 vs current $16.16